The findings are to a some extent in agreement with the recent findings on the metabolic changes associated with enhanced glucolysis in G6PD-deficient hepatoma cells [34] and human G6PD-deficient RBCs in response to diamide [33]. Here, G6PD is linked to hepatocellular carcinoma.